Paper25955428
A mathematical model to elucidate brain tumor abrogation by immunotherapy with T11 target structure.
Banerjee S and 2 others. PLoS One, 2015. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. A mathematical model to elucidate brain tumor abrogation by immunotherapy with T11 target structure. Papers, record 25955428. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25955428
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A mathematical model to elucidate brain tumor abrogation by immunotherapy with T11 target structure.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Immunotherapy | Major topic |
| Membrane Glycoproteins | Major topic |
| Models, Biological | Major topic |
| Animals | |
| Animals, Newborn | |
| CD8-Positive T-Lymphocytes | |
| Female | |
| Glioma | |
| Humans | |
| Interferon-gamma | |
| Least-Squares Analysis | |
| Macrophages | |
| Male | |
| Numerical Analysis, Computer-Assisted | |
| Rats | |
| Sheep | |
| Transforming Growth Factor beta |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10587310 | The detection of CD2+, CD4+, CD8+, and WC1+ T lymphocytes, B cells and macrophages in fixed and paraffin embedded bovine tissue using a range of antigen recovery and signal amplification techniques. | Vet Immunol Immunopathol | 1999 | https://conductscience.org/library/papers/10587310 | PubMed |
| 2 | 8953256 | Drug delivery to brain tumors. | Bull Math Biol | 1996 | https://conductscience.org/library/papers/8953256 | PubMed |
| 3 | 11895036 | The WHO classification of tumors of the nervous system. | J Neuropathol Exp Neurol | 2002 | https://conductscience.org/library/papers/11895036 | PubMed |
| 4 | 12716291 | Preclinical Changes in Immunoreactivity and Cellular Architecture during the Progressive Development of Intracranial Neoplasms and an Immunotherapeutic Schedule with a Novel Biological Response Modifier, the T11TS / S-LFA3. | Asian Pac J Cancer Prev | 2002 | https://conductscience.org/library/papers/12716291 | PubMed |
| 5 | 16227278 | How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill? | J Virol | 2005 | https://conductscience.org/library/papers/16227278 | PubMed |
| 6 | 10757345 | Immunosuppression mediated by tumor cells: a challenge for immunotherapeutic approaches. | Hum Gene Ther | 2000 | https://conductscience.org/library/papers/10757345 | PubMed |
| 7 | 19345698 | Distributed parameters deterministic model for treatment of brain tumors using Galerkin finite element method. | Math Biosci | 2009 | https://conductscience.org/library/papers/19345698 | PubMed |
| 8 | 19489983 | Virtual glioblastoma: growth, migration and treatment in a three-dimensional mathematical model. | Cell Prolif | 2009 | https://conductscience.org/library/papers/19489983 | PubMed |
| 9 | 22205943 | miR451 and AMPK mutual antagonism in glioma cell migration and proliferation: a mathematical model. | PLoS One | 2011 | https://conductscience.org/library/papers/22205943 | PubMed |
| 10 | 1312305 | Glioblastoma, transforming growth factor-beta, and Candida meningitis: a potential link. | Am J Med | 1992 | https://conductscience.org/library/papers/1312305 | PubMed |
| 11 | 16237114 | Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma. | J Immunol | 2005 | https://conductscience.org/library/papers/16237114 | PubMed |
| 12 | 16547267 | Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection. | J Immunol | 2006 | https://conductscience.org/library/papers/16547267 | PubMed |
| 13 | 8586458 | Histopathology, classification, and grading of gliomas. | Glia | 1995 | https://conductscience.org/library/papers/8586458 | PubMed |
| 14 | 12675529 | Quantifying efficacy of chemotherapy of brain tumors with homogeneous and heterogeneous drug delivery. | Acta Biotheor | 2002 | https://conductscience.org/library/papers/12675529 | PubMed |
| 15 | 10736214 | Simulated brain tumor growth dynamics using a three-dimensional cellular automaton. | J Theor Biol | 2000 | https://conductscience.org/library/papers/10736214 | PubMed |
| 16 | 11596120 | Basic principles of immunological surveillance of the normal central nervous system. | Glia | 2001 | https://conductscience.org/library/papers/11596120 | PubMed |
| 17 | 12242114 | Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. | Radiother Oncol | 2002 | https://conductscience.org/library/papers/12242114 | PubMed |
| 18 | 17823798 | Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics. | Cancer Immunol Immunother | 2008 | https://conductscience.org/library/papers/17823798 | PubMed |
| 19 | 14648016 | Interferon-gamma pharmacokinetics and pharmacodynamics in patients with colorectal cancer. | Cancer Chemother Pharmacol | 2004 | https://conductscience.org/library/papers/14648016 | PubMed |
| 20 | 15758009 | Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15758009 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41794979 | Fractional spatiotemporal Hahnfeldt tumor model with convergence analysis and optimal control. | Sci Rep | 2026 | https://conductscience.org/library/papers/41794979 | PubMed |
| 39155294 | Spatial computational modelling illuminates the role of the tumour microenvironment for treating glioblastoma with immunotherapies. | NPJ Syst Biol Appl | 2024 | https://conductscience.org/library/papers/39155294 | PubMed |
| 38099947 | Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma. | J Math Biol | 2023 | https://conductscience.org/library/papers/38099947 | PubMed |
| 36428963 | Distinct Dynamics of Migratory Response to PD-1 and CTLA-4 Blockade Reveals New Mechanistic Insights for Potential T-Cell Reinvigoration following Immune Checkpoint Blockade. | Cells | 2022 | https://conductscience.org/library/papers/36428963 | PubMed |
| 35814367 | KDELR1 Is an Independent Prognostic Predictor and Correlates With Immunity in Glioma. | Front Oncol | 2022 | https://conductscience.org/library/papers/35814367 | PubMed |
| 35482133 | Simulating the behaviour of glioblastoma multiforme based on patient MRI during treatments. | J Math Biol | 2022 | https://conductscience.org/library/papers/35482133 | PubMed |
| 35205057 | A Continuous Markov-Chain Model for the Simulation of COVID-19 Epidemic Dynamics. | Biology (Basel) | 2022 | https://conductscience.org/library/papers/35205057 | PubMed |
| 35125654 | Mathematical modeling and optimal intervention strategies of the COVID-19 outbreak. | Nonlinear Dyn | 2022 | https://conductscience.org/library/papers/35125654 | PubMed |
| 35070618 | Modeling the dynamics of COVID-19 pandemic with implementation of intervention strategies. | Eur Phys J Plus | 2022 | https://conductscience.org/library/papers/35070618 | PubMed |
| 34789751 | Spatiotemporal dynamics of a glioma immune interaction model. | Sci Rep | 2021 | https://conductscience.org/library/papers/34789751 | PubMed |
| 34771476 | An Agent-Based Model of Combination Oncolytic Viral Therapy and Anti-PD-1 Immunotherapy Reveals the Importance of Spatial Location When Treating Glioblastoma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34771476 | PubMed |
| 34631341 | Dynamics of coronavirus pandemic: effects of community awareness and global information campaigns. | Eur Phys J Plus | 2021 | https://conductscience.org/library/papers/34631341 | PubMed |
| 34423116 | An in silico glioblastoma microenvironment model dissects the immunological mechanisms of resistance to PD-1 checkpoint blockade immunotherapy. | Small Methods | 2021 | https://conductscience.org/library/papers/34423116 | PubMed |
| 33977079 | Mathematical modeling of the COVID-19 pandemic with intervention strategies. | Results Phys | 2021 | https://conductscience.org/library/papers/33977079 | PubMed |
| 33922302 | Personalized Immunotherapy Treatment Strategies for a Dynamical System of Chronic Myelogenous Leukemia. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33922302 | PubMed |
| 33846838 | Multiscale modeling of glioma pseudopalisades: contributions from the tumor microenvironment. | J Math Biol | 2021 | https://conductscience.org/library/papers/33846838 | PubMed |
| 33679275 | Impact of social media advertisements on the transmission dynamics of COVID-19 pandemic in India. | J Appl Math Comput | 2022 | https://conductscience.org/library/papers/33679275 | PubMed |
| 32834653 | A mathematical model for COVID-19 transmission dynamics with a case study of India. | Chaos Solitons Fractals | 2020 | https://conductscience.org/library/papers/32834653 | PubMed |
| 32834603 | Modeling and forecasting the COVID-19 pandemic in India. | Chaos Solitons Fractals | 2020 | https://conductscience.org/library/papers/32834603 | PubMed |
| 32752627 | Forecasting the daily and cumulative number of cases for the COVID-19 pandemic in India. | Chaos | 2020 | https://conductscience.org/library/papers/32752627 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AP1M2 | 10053 | PubTator's text mining | https://conductscience.org/library/genes/10053 | NCBI Gene |
| CD2 | 914 | PubTator's text mining | https://conductscience.org/library/genes/914 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| EDN1 | 1906 | PubTator's text mining | https://conductscience.org/library/genes/1906 | NCBI Gene |
| EDN3 | 1908 | PubTator's text mining | https://conductscience.org/library/genes/1908 | NCBI Gene |
| IGKV2D-28 | 28883 | PubTator's text mining | https://conductscience.org/library/genes/28883 | NCBI Gene |
| IL10 | 3586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
| MIR451A | 574411 | PubTator's text mining | https://conductscience.org/library/genes/574411 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25955428
GET https://conductscience.org/api/papers/v1/25955428/references?page=2